Venture Investors, LLC is a venture capital firm established in 1982 and headquartered in Madison, Wisconsin, with additional offices in Ann Arbor and Milwaukee. The firm specializes in seed, early-stage, and growth financing, primarily focusing on the healthcare sector, including biotechnology, diagnostics, medical devices, and digital health. It also invests in agriculture, technology, clean tech, material sciences, and energy technology, with a particular interest in startups that have licensed technology from research universities in the Midwest, such as the University of Wisconsin-Madison. Venture Investors typically makes seed investments ranging from $0.25 million to $2.5 million and prefers to invest in the form of preferred stock or debt with warrant coverage. The firm aims to lead investment rounds and usually holds its investments for five to seven years, looking for opportunities that will significantly impact health and wellness. With over $200 million in assets under management, Venture Investors leverages its connections to renowned research institutions and vibrant communities to identify and support innovative ideas.
Delphinus Medical Technologies, Inc. is a medical imaging company based in Plymouth, Michigan, with a satellite office in Sunnyvale, California. Founded in 2009, the company specializes in developing and commercializing SoftVue, an innovative ultrasound technology designed for comprehensive breast imaging. This circular array transducer system provides three-dimensional and tomographic imaging, allowing for the examination of women's breasts to detect both benign and malignant masses, assess breast cancer risks, diagnose breast diseases, and monitor treatment. Delphinus serves hospitals and imaging clinics across the United States and internationally, offering a non-invasive, radiation-free solution that enhances the early detection of breast cancer while prioritizing patient comfort.
SkySpecs
Series C in 2019
SkySpecs, Inc. specializes in developing unmanned aerial vehicles and associated technologies to automate operations and maintenance within the wind energy sector. Founded in 2012 and headquartered in Ann Arbor, Michigan, with an additional office in Amsterdam, the company offers a range of services including analytics, engineering projects, and wind turbine blade services. Its solutions feature collaborative software for data management and analysis, digitization of data, and comprehensive planning for repair campaigns. SkySpecs also provides Horizon, a reporting and collaboration tool that serves as a central repository for blade operation and maintenance data, facilitating streamlined tasks and communication with third parties. The company's focus is on enhancing productivity, efficiency, and returns for its clients in renewable energy asset management.
SkySpecs
Series B in 2018
SkySpecs, Inc. specializes in developing unmanned aerial vehicles and associated technologies to automate operations and maintenance within the wind energy sector. Founded in 2012 and headquartered in Ann Arbor, Michigan, with an additional office in Amsterdam, the company offers a range of services including analytics, engineering projects, and wind turbine blade services. Its solutions feature collaborative software for data management and analysis, digitization of data, and comprehensive planning for repair campaigns. SkySpecs also provides Horizon, a reporting and collaboration tool that serves as a central repository for blade operation and maintenance data, facilitating streamlined tasks and communication with third parties. The company's focus is on enhancing productivity, efficiency, and returns for its clients in renewable energy asset management.
SkySpecs
Series A in 2015
SkySpecs, Inc. specializes in developing unmanned aerial vehicles and associated technologies to automate operations and maintenance within the wind energy sector. Founded in 2012 and headquartered in Ann Arbor, Michigan, with an additional office in Amsterdam, the company offers a range of services including analytics, engineering projects, and wind turbine blade services. Its solutions feature collaborative software for data management and analysis, digitization of data, and comprehensive planning for repair campaigns. SkySpecs also provides Horizon, a reporting and collaboration tool that serves as a central repository for blade operation and maintenance data, facilitating streamlined tasks and communication with third parties. The company's focus is on enhancing productivity, efficiency, and returns for its clients in renewable energy asset management.
Delphinus Medical Technologies
Series C in 2015
Delphinus Medical Technologies, Inc. is a medical imaging company based in Plymouth, Michigan, with a satellite office in Sunnyvale, California. Founded in 2009, the company specializes in developing and commercializing SoftVue, an innovative ultrasound technology designed for comprehensive breast imaging. This circular array transducer system provides three-dimensional and tomographic imaging, allowing for the examination of women's breasts to detect both benign and malignant masses, assess breast cancer risks, diagnose breast diseases, and monitor treatment. Delphinus serves hospitals and imaging clinics across the United States and internationally, offering a non-invasive, radiation-free solution that enhances the early detection of breast cancer while prioritizing patient comfort.
NeuMoDx Molecular
Series B in 2014
NeuMoDx Molecular, Inc. is a molecular diagnostics company based in Ann Arbor, Michigan, founded in 2012. It specializes in developing solutions for molecular diagnostic testing in hospital and clinical reference laboratories. The company’s platform provides in-vitro testing tools that enhance the efficiency and cost-effectiveness of laboratory operations. By improving the capabilities of laboratory professionals, NeuMoDx aims to increase the adoption of molecular diagnostic testing among medical providers, facilitating earlier and more accurate disease identification and treatment. In 2013, NeuMoDx changed its name from Molecular Systems Corporation and has since become a subsidiary of QIAGEN N.V.
UpTo
Series A in 2014
UpTo is a modern calendar that gives a more complete view of everything coming up that matters without the clutter. It creates a beautiful web calendar for their business or organization. The platform brings calendar to life and allows them to easily add events, without an IT department. Add events through an online account and watch them sync seamlessly across UpTo's mobile app and web calendars. Upto was established in 2011 and is based in Detroit, Michigan, United States.
Tissue Regeneration Systems
Series B in 2013
Tissue Regeneration Systems Inc. is a start-up medical device company based in Plymouth, Michigan, with an additional office in Kirkland, Washington, and a research facility in Ann Arbor, Michigan. Founded in 2005, the company specializes in a skeletal reconstruction and bone regeneration technology licensed from the Universities of Michigan and Wisconsin. This innovative technology is applicable in various medical fields, including craniomaxillofacial surgery, orthopedic surgery, spine fusion surgery, and the delivery of bone growth factors. The company's devices utilize a biodegradable polyester polymer to facilitate spinal implants and repair damaged bones, enhancing surgical outcomes for conditions such as fractured orbital sockets and facial deformities. Tissue Regeneration Systems has successfully completed bench and animal testing and has filed initial regulatory submissions to the FDA, with expectations to commercialize its products in the United States and begin generating revenue in the coming years.
UpTo
Series A in 2013
UpTo is a modern calendar that gives a more complete view of everything coming up that matters without the clutter. It creates a beautiful web calendar for their business or organization. The platform brings calendar to life and allows them to easily add events, without an IT department. Add events through an online account and watch them sync seamlessly across UpTo's mobile app and web calendars. Upto was established in 2011 and is based in Detroit, Michigan, United States.
BlueWillow Biologics
Series C in 2012
BlueWillow Biologics, a clinical-stage biopharmaceutical company based in Ann Arbor, Michigan, specializes in the development of intranasal vaccines and anti-infective products utilizing its patented nanotechnology platform. The company's innovative NanoStat vaccine technology incorporates a unique oil-in-water nanoemulsion, allowing for the effective delivery and adjuvant of various antigens. BlueWillow focuses on vaccines for respiratory and sexually transmitted diseases, including pertussis, pandemic influenza, anthrax, and HIV, as well as providing NanoBio Protect, a nasal antiseptic solution. The company also has a licensing agreement with Merck for the use of its adjuvant in intranasal vaccines for respiratory syncytial virus (RSV) and seasonal influenza. Founded in 1999 as a spin-off from the University of Michigan, BlueWillow Biologics aims to enhance mucosal immunity through its advanced vaccine technology.
BlueWillow Biologics
Series B in 2009
BlueWillow Biologics, a clinical-stage biopharmaceutical company based in Ann Arbor, Michigan, specializes in the development of intranasal vaccines and anti-infective products utilizing its patented nanotechnology platform. The company's innovative NanoStat vaccine technology incorporates a unique oil-in-water nanoemulsion, allowing for the effective delivery and adjuvant of various antigens. BlueWillow focuses on vaccines for respiratory and sexually transmitted diseases, including pertussis, pandemic influenza, anthrax, and HIV, as well as providing NanoBio Protect, a nasal antiseptic solution. The company also has a licensing agreement with Merck for the use of its adjuvant in intranasal vaccines for respiratory syncytial virus (RSV) and seasonal influenza. Founded in 1999 as a spin-off from the University of Michigan, BlueWillow Biologics aims to enhance mucosal immunity through its advanced vaccine technology.
Tissue Regeneration Systems
Series A in 2008
Tissue Regeneration Systems Inc. is a start-up medical device company based in Plymouth, Michigan, with an additional office in Kirkland, Washington, and a research facility in Ann Arbor, Michigan. Founded in 2005, the company specializes in a skeletal reconstruction and bone regeneration technology licensed from the Universities of Michigan and Wisconsin. This innovative technology is applicable in various medical fields, including craniomaxillofacial surgery, orthopedic surgery, spine fusion surgery, and the delivery of bone growth factors. The company's devices utilize a biodegradable polyester polymer to facilitate spinal implants and repair damaged bones, enhancing surgical outcomes for conditions such as fractured orbital sockets and facial deformities. Tissue Regeneration Systems has successfully completed bench and animal testing and has filed initial regulatory submissions to the FDA, with expectations to commercialize its products in the United States and begin generating revenue in the coming years.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.